- About us
- Access our Services
- Scientific strategy
Follow our twitter: @ERINHA_RI
You can contact us here
Access to our intranet here
Download our portfolio here
Date: 09 May, 2022
A new publication has been added to the scientific literature on infectious diseases. It is an article published in French in the journal médecine/science 2022; 38: 335-6.
This article examines the scientific and public responses to infectious diseases as epidemics accelerate and become more frequent. During the last epidemics since the 1970s, the observation has been the same: weakness in the capacity for early detection, absence of therapeutic means available or ready to enter clinical trials, difficulty in developing and implementing preventive measures and prediction tools, all of which reflect a lack of anticipation and preparation. The article seeks to draw attention to and mobilise on the issue of preparedness in order to better anticipate and cope with future epidemics or the emergence of new infectious diseases.
The article is available in French here: https://doi.org/10.1051/medsci/2022056
ERINHA is a pan-European distributed Research Infrastructure dedicated to the study of high-consequence emerging and re-emerging pathogens. It brings together leading European high containment facilities with longstanding experience of research in the field of highly infectious diseases and offers a coordinated access to them to academic and private sector scientists.
ERINHA’s mission is to advance research on high consequence (re)emerging diseases and to contribute to protecting human health by increasing Europe’s preparedness for, and capability to respond to, highly pathogenic infectious threats.
The National Agency for Research on AIDS and Viral Hepatitis (ANRS) | Emerging Infectious Diseases, created on 1 January 2021, is an autonomous agency of Inserm. Its mission is to lead, evaluate, coordinate and finance research on HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases (in particular emerging respiratory infections, including Covid-19, viral haemorrhagic fevers and arboviroses) It is headed by a director, Prof. Yazdan Yazdanpanah. The deputy director in charge of infrastructures and European affairs is Dr Hervé Raoul.